{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:05:22Z","timestamp":1784610322546,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260627"],"award-info":[{"award-number":["82260627"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12257-0","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:30:07Z","timestamp":1784608207000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of STRA6 induced by ONECUT2 drives malignant progression and radioresistance in rectal cancer through activating the Wnt\/\u03b2-Catenin signaling pathway"],"prefix":"10.1007","volume":"53","author":[{"given":"Feifeng","family":"Ran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1935-4100","authenticated-orcid":false,"given":"Leifeng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"issue":"3","key":"12257_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel R, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"Cancer J Clin"},{"key":"12257_CR2","doi-asserted-by":"publisher","first-page":"iv22","DOI":"10.1093\/annonc\/mdx224","volume":"28","author":"R Glynne-Jones","year":"2017","unstructured":"Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, R\u00f6del C, Cervantes A, Arnold D (2017) Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals oncology: official J Eur Soc Med Oncol 28:iv22\u2013iv40. https:\/\/doi.org\/10.1093\/annonc\/mdx224","journal-title":"Annals oncology: official J Eur Soc Med Oncol"},{"issue":"6","key":"12257_CR3","doi-asserted-by":"publisher","first-page":"e180071","DOI":"10.1001\/jamaoncol.2018.0071","volume":"4","author":"A Cercek","year":"2018","unstructured":"Cercek A, Roxburgh C, Strombom P, Smith J, Temple L, Nash G, Guillem J, Paty P, Yaeger R, Stadler Z et al (2018) Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer. JAMA Oncol 4(6):e180071. https:\/\/doi.org\/10.1001\/jamaoncol.2018.0071","journal-title":"JAMA Oncol"},{"issue":"10182","key":"12257_CR4","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/s0140-6736(18)33203-3","volume":"393","author":"E Esen","year":"2019","unstructured":"Esen E, Karahasano\u011flu T, \u00d6zben V, Ayta\u00e7 E, Baca B, Hamzao\u011flu \u0130, Remzi F (2019) Complete response after neoadjuvant treatment for rectal cancer. Lancet 393(10182):1694. https:\/\/doi.org\/10.1016\/s0140-6736(18)33203-3","journal-title":"Lancet"},{"key":"12257_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1749-6632.2000.tb06714.x","volume":"910","author":"F Buchegger","year":"2000","unstructured":"Buchegger F, Roth A, Allal A, Dupertuis Y, Slosman D, Delaloye A, Mach J (2000) Radioimmunotherapy of colorectal cancer liver metastases: combination with radiotherapy. Ann N Y Acad Sci 910:263\u2013269 discussion 269\u2013270. https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb06714.x","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"12257_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-020-01171-z","volume":"19","author":"X Zhang","year":"2020","unstructured":"Zhang X, Xie K, Zhou H, Wu Y, Li C, Liu Y, Liu Z, Xu Q, Liu S, Xiao D et al (2020) Role of non-coding RNAs and RNA modifiers in cancer therapy resistance. Mol Cancer 19(1):47. https:\/\/doi.org\/10.1186\/s12943-020-01171-z","journal-title":"Mol Cancer"},{"issue":"5813","key":"12257_CR7","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1126\/science.1136244","volume":"315","author":"R Kawaguchi","year":"2007","unstructured":"Kawaguchi R, Yu J, Honda J, Hu J, Whitelegge J, Ping P, Wiita P, Bok D, Sun H (2007) A Membrane Receptor for Retinol Binding Protein Mediates Cellular Uptake of Vitamin A. Science 315(5813):820\u2013825","journal-title":"Science"},{"issue":"3","key":"12257_CR8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.cmet.2008.01.009","volume":"7","author":"A Isken","year":"2008","unstructured":"Isken A, Golczak M, Oberhauser V, Hunzelmann S, Driever W, Imanishi Y, Palczewski K, von Lintig J (2008) RBP4 disrupts vitamin A uptake homeostasis in a STRA6-deficient animal model for Matthew-Wood syndrome. Cell Metab 7(3):258\u2013268. https:\/\/doi.org\/10.1016\/j.cmet.2008.01.009","journal-title":"Cell Metab"},{"issue":"6","key":"12257_CR9","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1074\/jbc.273.6.3336","volume":"273","author":"M Sundaram","year":"1998","unstructured":"Sundaram M, Sivaprasadarao A, DeSousa MM, Findlay JB (1998) The transfer of retinol from serum retinol-binding protein to cellular retinol-binding protein is mediated by a membrane receptor. J Biol Chem 273(6):3336\u20133342. https:\/\/doi.org\/10.1074\/jbc.273.6.3336","journal-title":"J Biol Chem"},{"key":"12257_CR10","doi-asserted-by":"publisher","unstructured":"Karunanithi S, Levi L, DeVecchio J, Karagkounis G, Reizes O, Lathia JD, Kalady MF, Noy N RBP4-STRA6 Pathway Drives Cancer Stem Cell Maintenance and Mediates High-Fat Diet-Induced Colon Carcinogenesis. Stem Cell Rep 2017, 9(2):438\u2013450. https:\/\/doi.org\/10.1016\/j.stemcr.2017.06.002","DOI":"10.1016\/j.stemcr.2017.06.002"},{"key":"12257_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1749-6632.2009.04911.x","volume":"1171","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal BB, Kunnumakkara AB, Harikumar KB, Gupta SR, Tharakan ST, Koca C, Dey S, Sung B (2009) Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann N Y Acad Sci 1171:59\u201376. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.04911.x","journal-title":"Ann N Y Acad Sci"},{"key":"12257_CR12","doi-asserted-by":"publisher","unstructured":"Zhu F, Wang KB, Rui L (2019) STAT3 Activation and Oncogenesis in Lymphoma. Cancers (Basel) 12(1). https:\/\/doi.org\/10.3390\/cancers12010019","DOI":"10.3390\/cancers12010019"},{"issue":"1","key":"12257_CR13","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s13046-019-1450-2","volume":"38","author":"L Lin","year":"2019","unstructured":"Lin L, Xiao J, Shi L, Chen W, Ge Y, Jiang M, Li Z, Fan H, Yang L, Xu Z (2019) STRA6 exerts oncogenic role in gastric tumorigenesis by acting as a crucial target of miR-873. J experimental Clin cancer research: CR 38(1):452. https:\/\/doi.org\/10.1186\/s13046-019-1450-2","journal-title":"J experimental Clin cancer research: CR"},{"issue":"3","key":"12257_CR14","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1007\/s11010-024-05085-y","volume":"480","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Zhou R, Wang N, Zhao T, Qiu P, Gao C, Chang M, Lin N, Zhang X, Li JZ et al (2025) Inhibition of STRA6 suppresses NSCLC growth via blocking STAT3\/SREBP-1c axis-mediated lipogenesis. Mol Cell Biochem 480(3):1715\u20131730. https:\/\/doi.org\/10.1007\/s11010-024-05085-y","journal-title":"Mol Cell Biochem"},{"key":"12257_CR15","doi-asserted-by":"publisher","unstructured":"Fan Y, Peiwen X, Surui Y, Min L, Zehua B, Zhaohui H (2023) Up-regulation of STRA6 predicts poor prognosis and contributes to oxaliplatin resistance in colorectal cancer. Pathol Res Pract 243(0). https:\/\/doi.org\/10.1016\/j.prp.2023.154352","DOI":"10.1016\/j.prp.2023.154352"},{"issue":"21","key":"12257_CR16","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.1158\/0008-5472.Can-14-1052","volume":"74","author":"D Berry","year":"2014","unstructured":"Berry D, Levi L, Noy N (2014) Holo-retinol-binding protein and its receptor STRA6 drive oncogenic transformation. Cancer Res 74(21):6341\u20136351. https:\/\/doi.org\/10.1158\/0008-5472.Can-14-1052","journal-title":"Cancer Res"},{"key":"12257_CR17","doi-asserted-by":"publisher","unstructured":"Karunanithi S, Levi L, DeVecchio J, Karagkounis G, Reizes O, Lathia J, Kalady M, Noy N RBP4-STRA6 Pathway Drives Cancer Stem Cell Maintenance and Mediates High-Fat Diet-Induced Colon Carcinogenesis. Stem cell Rep 2017, 9(2):438\u2013450. https:\/\/doi.org\/10.1016\/j.stemcr.2017.06.002","DOI":"10.1016\/j.stemcr.2017.06.002"},{"key":"12257_CR18","doi-asserted-by":"publisher","unstructured":"Daniel CB, Liraz L, Noa N (2014) Holo-retinol-binding protein and its receptor STRA6 drive oncogenic transformation. Cancer Res 74(21). https:\/\/doi.org\/10.1158\/0008-5472.Can-14-1052","DOI":"10.1158\/0008-5472.Can-14-1052"},{"issue":"3","key":"12257_CR19","doi-asserted-by":"publisher","first-page":"100625","DOI":"10.1016\/j.xinn.2024.100625","volume":"5","author":"B Gy\u0151rffy","year":"2024","unstructured":"Gy\u0151rffy B (2024) Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innov (Cambridge (Mass) 5(3):100625. https:\/\/doi.org\/10.1016\/j.xinn.2024.100625","journal-title":"Innov (Cambridge (Mass)"},{"key":"12257_CR20","doi-asserted-by":"publisher","unstructured":"Trakarnsanga A, G\u00f6nen M, Shia J, Nash G, Temple L, Guillem J, Paty P, Goodman K, Wu A, Gollub M et al (2014) Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment. J Natl Cancer Inst 106(10). https:\/\/doi.org\/10.1093\/jnci\/dju248","DOI":"10.1093\/jnci\/dju248"},{"issue":"2","key":"12257_CR21","doi-asserted-by":"publisher","first-page":"272","DOI":"10.4103\/jcrt.JCRT_421_18","volume":"15","author":"Y Yang","year":"2019","unstructured":"Yang Y, Zhou H, Zhang G, Xue X (2019) Targeting the canonical Wnt\/\u03b2-catenin pathway in cancer radioresistance: Updates on the molecular mechanisms. J Cancer Res Ther 15(2):272\u2013277. https:\/\/doi.org\/10.4103\/jcrt.JCRT_421_18","journal-title":"J Cancer Res Ther"},{"key":"12257_CR22","doi-asserted-by":"publisher","first-page":"216641","DOI":"10.1016\/j.canlet.2024.216641","volume":"589","author":"Y Liu","year":"2024","unstructured":"Liu Y, Shi J, Liu W, Tang Y, Shu X, Wang R, Chen Y, Shi X, Jin J, Li D (2024) A deep neural network predictor to predict the sensitivity of neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Cancer Lett 589:216641. https:\/\/doi.org\/10.1016\/j.canlet.2024.216641","journal-title":"Cancer Lett"},{"key":"12257_CR23","doi-asserted-by":"publisher","unstructured":"Yang F, Xu P, Yao S, Li M, Bian Z, Huang Z Up-regulation of STRA6 predicts poor prognosis and contributes to oxaliplatin resistance in colorectal cancer. Pathol Res Pract 2023, 243:154352. https:\/\/doi.org\/10.1016\/j.prp.2023.154352","DOI":"10.1016\/j.prp.2023.154352"},{"key":"12257_CR24","doi-asserted-by":"publisher","unstructured":"Lizardo D, Kuang C, Hao S, Yu J, Huang Y, Zhang L Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside. Biochim et Biophys acta Reviews cancer 2020, 1874(2):188447. https:\/\/doi.org\/10.1016\/j.bbcan.2020.188447","DOI":"10.1016\/j.bbcan.2020.188447"},{"issue":"4","key":"12257_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrclinonc.2016.171","volume":"14","author":"C Punt","year":"2017","unstructured":"Punt C, Koopman M, Vermeulen L (2017) From tumour heterogeneity to advances in precision treatment of colorectal cancer. Nat reviews Clin Oncol 14(4):235\u2013246. https:\/\/doi.org\/10.1038\/nrclinonc.2016.171","journal-title":"Nat reviews Clin Oncol"},{"key":"12257_CR26","doi-asserted-by":"publisher","unstructured":"Modest D, Pant S, Sartore-Bianchi A (2019) Treatment sequencing in metastatic colorectal cancer. Eur J cancer (Oxford England: 1990) 109:70\u201383. https:\/\/doi.org\/10.1016\/j.ejca.2018.12.019","DOI":"10.1016\/j.ejca.2018.12.019"},{"issue":"1","key":"12257_CR27","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1186\/s13046-019-1405-7","volume":"38","author":"S Park","year":"2019","unstructured":"Park S, Lee C, Choi J, Kim J, Kim J, Kim J, Nam J (2019) The JAK2\/STAT3\/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance. J experimental Clin cancer research: CR 38(1):399. https:\/\/doi.org\/10.1186\/s13046-019-1405-7","journal-title":"J experimental Clin cancer research: CR"},{"issue":"3","key":"12257_CR28","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1007\/s11010-024-05085-y","volume":"480","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Zhou R, Wang N, Zhao T, Qiu P, Gao C, Chang M, Lin N, Zhang X, Li J et al (2025) Inhibition of STRA6 suppresses NSCLC growth via blocking STAT3\/SREBP-1c axis-mediated lipogenesis. Mol Cell Biochem 480(3):1715\u20131730. https:\/\/doi.org\/10.1007\/s11010-024-05085-y","journal-title":"Mol Cell Biochem"},{"issue":"10","key":"12257_CR29","first-page":"4197","volume":"61","author":"W Szeto","year":"2001","unstructured":"Szeto W, Jiang W, Tice DA, Rubinfeld B, Pennica D (2001) Overexpression of the retinoic acid-responsive gene Stra6 in human cancers and its synergistic induction by Wnt-1 and retinoic acid. Cancer Res 61(10):4197\u20134205","journal-title":"Cancer Res"},{"issue":"15","key":"12257_CR30","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1128\/mcb.00505-12","volume":"32","author":"D Berry","year":"2012","unstructured":"Berry D, O\u2019Byrne S, Vreeland A, Blaner W, Noy N (2012) Cross talk between signaling and vitamin A transport by the retinol-binding protein receptor STRA6. Mol Cell Biol 32(15):3164\u20133175. https:\/\/doi.org\/10.1128\/mcb.00505-12","journal-title":"Mol Cell Biol"},{"key":"12257_CR31","doi-asserted-by":"publisher","unstructured":"Gisele HJML, Daphne H, Frank PS, Sander AJ, Hans dJ, Willem JGM, Erik BC, Theo M, dR, Henk V, Paul K et al (2015) Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer. Clin Cancer Res 21(13). https:\/\/doi.org\/10.1158\/1078-0432.Ccr-14-3334","DOI":"10.1158\/1078-0432.Ccr-14-3334"},{"key":"12257_CR32","doi-asserted-by":"publisher","unstructured":"Branislava R, Nina Z, Margareta \u017d, Emanuela B (2019) Epithelial-Mesenchymal Transition-Related MicroRNAs and Their Target Genes in Colorectal Cancerogenesis. J Clin Med 8(10). https:\/\/doi.org\/10.3390\/jcm8101603","DOI":"10.3390\/jcm8101603"},{"issue":"12","key":"12257_CR33","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1038\/s41591-018-0241-1","volume":"24","author":"M Rotinen","year":"2018","unstructured":"Rotinen M, You S, Yang J, Coetzee S, Reis-Sobreiro M, Huang W, Huang F, Pan X, Y\u00e1\u00f1ez A, Hazelett D et al (2018) ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis. Nat Med 24(12):1887\u20131898. https:\/\/doi.org\/10.1038\/s41591-018-0241-1","journal-title":"Nat Med"},{"key":"12257_CR34","doi-asserted-by":"publisher","unstructured":"Yingnan S, Shourong S, Xiaoping L, Hailin T, Zeyou W, Zhibin Y, Xiayu L, Minghua W (2014) MiR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma. Mol Cell Biochem 390(0). https:\/\/doi.org\/10.1007\/s11010-013-1950-x","DOI":"10.1007\/s11010-013-1950-x"},{"issue":"1","key":"12257_CR35","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41420-021-00754-z","volume":"7","author":"V Dhokia","year":"2021","unstructured":"Dhokia V, Macip S (2021) A master of all trades - linking retinoids to different signalling pathways through the multi-purpose receptor STRA6. Cell death discovery 7(1):358. https:\/\/doi.org\/10.1038\/s41420-021-00754-z","journal-title":"Cell death discovery"},{"key":"12257_CR36","doi-asserted-by":"publisher","unstructured":"Xiao Y, Fengming L, Tingyi X (2019) Hypoxic Glioma Cell-Secreted Exosomal miR-301a Activates Wnt\/\u03b2-catenin Signaling and Promotes Radiation Resistance by Targeting TCEAL7. Mol Ther 27(11). https:\/\/doi.org\/10.1016\/j.ymthe.2019.07.011","DOI":"10.1016\/j.ymthe.2019.07.011"},{"key":"12257_CR37","doi-asserted-by":"publisher","unstructured":"Youn-Sang J, Sohee J, Moon Jong K, Sung Ho L, Han Na S, Esther ML, Hae-Yun J, Sunhye L, Jie Z, Jung-In Y et al (2018) TMEM9 promotes intestinal tumorigenesis through vacuolar-ATPase-activated Wnt\/\u03b2-catenin signalling. Nat Cell Biol 20(12). https:\/\/doi.org\/10.1038\/s41556-018-0219-8","DOI":"10.1038\/s41556-018-0219-8"},{"key":"12257_CR38","doi-asserted-by":"publisher","unstructured":"Satoru O, Dan Z, Zhaobin Z, Chaoxi L, Christian TS, Oltea S, Jeffrey JO, Yancey G, Hideyuki G, Christopher S (2021) N-cadherin upregulation mediates adaptive radioresistance in glioblastoma. J Clin Invest 131(6). https:\/\/doi.org\/10.1172\/jci136098","DOI":"10.1172\/jci136098"},{"key":"12257_CR39","doi-asserted-by":"publisher","unstructured":"Jacey JL, Yanjie L, Wendy SC, Yan L, Gaowei W, Min Z, Kota K, Ruiyun X, Michael K, Gen-Sheng F (2018) Shp2 deletion in hepatocytes suppresses hepatocarcinogenesis driven by oncogenic \u03b2-Catenin, PIK3CA and MET. J Hepatol 69(1). https:\/\/doi.org\/10.1016\/j.jhep.2018.02.014","DOI":"10.1016\/j.jhep.2018.02.014"},{"issue":"6","key":"12257_CR40","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","volume":"149","author":"H Clevers","year":"2012","unstructured":"Clevers H, Nusse R (2012) Wnt\/\u03b2-catenin signaling and disease. Cell 149(6):1192\u20131205. https:\/\/doi.org\/10.1016\/j.cell.2012.05.012","journal-title":"Cell"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12257-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12257-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12257-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:30:10Z","timestamp":1784608210000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12257-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12257"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12257-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"15 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have no declaration to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The use of human rectal cancer tissues was approved by the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University (Approval No. 2025\u2011E0342) and the Ethics Committee of the Sixth Affiliated Hospital of Guangxi Medical University (Approval No. YLSY\u2011IRB\u2011SR\u20112025074). For pretreatment biopsy samples, written informed consent was obtained from all patients prior to sample collection. For surgically resected tissues, which were de\u2011identified archived specimens routinely collected during clinical care, the requirement for individual written informed consent was waived by both ethics committees due to the retrospective nature of the study, the use of anonymized tissues, and the minimal risk to participants. All animal experiments were approved by the Medical Laboratory Animal Ethics Committee of the First Affiliated Hospital of Guangxi Medical University (Approval No. 2025-D0332), and all animal procedures were performed in compliance with institutional guidelines for the care and use of laboratory animals.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1219"}}